
Apr 11, 2025, 15:47
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on X:
“Major microbiome disruption was associated with toxicities following ide-cel administration in patients with multiple myeloma.”
Authors: Satabdi Saha et al.
Abdur Rehman
cancer
Chia-Chi Chang
Christine Peterson
Christopher R. Flowers
Donna M Weber
Doris K. Hansen
Elizabeth J. Shpall
Faezeh Darbaniyan
Frederick L. Locke
Hans C. Lee
idecabtagene vicleucel
Krina K. Patel
Lubna Rehman
Mahmoud R Gaballa
Marco L. Davila
Mark R. Tanner
Meghan Menges
Melody Becnel
Michael D. Jain
Muzaffar Qazilbash
Neeraj Y Saini
OncoDaily
Oncology
Reetakshi Arora
Robert R Jenq
Robert Z. Orlowski
Salvatore Corallo
Satabdi Saha
Sattva S. Neelapu
Sheeba K. Thomas
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 04:10
Apr 14, 2025, 19:10
Apr 14, 2025, 19:01
Apr 14, 2025, 18:39
Apr 14, 2025, 18:22
Apr 14, 2025, 18:21